Franklin Street Advisors’s Core Laboratories CLB Stock Holding History

Franklin Street Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-78,347	Closed	-$9.07M	–	150
2018 Q3	$9.07M	Sell	78,347 -2,199	-3%	-$248K	1.23%	32
2018 Q2	$10.2M	Buy	80,546 +816	+1%	+$99.3K	1.48%	24
2018 Q1	$8.63M	Buy	79,730 +2,725	+4%	+$302K	1.29%	30
2017 Q4	$8.44M	Buy	77,005 +660	+0.9%	+$65.9K	1.26%	27
2017 Q3	$7.54M	Buy	76,345 +18,875	+33%	+$1.83M	1.24%	30
2017 Q2	$5.82M	Buy	57,470 +2,100	+4%	+$226K	1%	46
2017 Q1	$6.4M	Buy	55,370 +6,920	+14%	+$804K	1.13%	39
2016 Q4	$5.82M	Buy	48,450 +5,050	+12%	+$559K	1.03%	41
2016 Q3	$4.88M	Buy	+43,400	New	+$5M	0.89%	48

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Street Advisors's CLB Position: Q4 2018 in Review

Franklin Street Advisors sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 78,347 shares — an estimated $9.07M sold.

Franklin Street Advisors first reported a position in CLB in Q3 2016 and held it in 9 quarters. The position peaked at $10.2M in Q2 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Franklin Street Advisors reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Franklin Street Advisors sold 78,347 Core Laboratories shares in Q4 2018, an estimated $9.07M.
Franklin Street Advisors first reported a position in Core Laboratories in Q3 2016 and held it in 9 quarters.
Franklin Street Advisors's Core Laboratories position peaked at $10.2M in Q2 2018.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Franklin Street Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.